FDA Drug Application (204311) for ABACAVIR AND LAMIVUDINE by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number204311
Product Number001
FormTABLET, FOR SUSPENSION;ORAL
Dosage60MG;30MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABACAVIR AND LAMIVUDINE
Active IngredientABACAVIR;LAMIVUDINE



Back to FDA Applications sponsored by MYLAN LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.